» Authors » Bart Loeys

Bart Loeys

Explore the profile of Bart Loeys including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 165
Citations 4296
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Richer J, Velchev J, Goobie S, Boswell-Patterson C, van de Laar I, Verhagen J, et al.
J Med Genet . 2025 Jan; 62(3):199-205. PMID: 39746778
Background: Individuals harbouring pathogenic variants are at risk for aneurysms/dissections throughout the arterial tree. Based on prior reports of sex differences in thoracic aortic aneurysm/dissection, we investigated the sexual dimorphism...
2.
Elliott P, Schunkert H, Bondue A, Behr E, Carrier L, van Duijn C, et al.
Eur Heart J . 2024 Dec; 46(4):344-353. PMID: 39673718
In the modern era, cardiologists managing patients and families with cardiomyopathies need to be familiar with every stage of the diagnostic pathway from clinical phenotyping to the prescription and interpretation...
3.
De Clercq G, Vantomme L, Dewaele B, Callewaert B, Vanakker O, Janssens S, et al.
Sci Rep . 2024 Nov; 14(1):29142. PMID: 39587234
Structural variants (SVs) are important contributors to human disease. Their characterization remains however difficult due to their size and association with repetitive regions. Long-read sequencing (LRS) and optical genome mapping...
4.
Boen H, Vandendriessche B, Schippers J, Rabaut L, Nijak-Paeske A, Ponsaerts P, et al.
Stem Cell Res . 2024 Aug; 81:103536. PMID: 39167847
Truncating variants in TTN (TTNtv) are present in 15-25 % of patients with idiopathic dilated cardiomyopathy. Interestingly, the pathogenicity of TTNtv seems to be linked to their location within the...
5.
Totten V, Teixido-Tura G, Lopez-Grondona F, Fernandez-Alvarez P, Lasa-Aranzasti A, Munoz-Cabello P, et al.
J Med Genet . 2024 Jul; 61(9):870-877. PMID: 38960581
Background: Tatton-Brown-Rahman syndrome (TBRS) is a rare disorder, caused by heterozygous pathogenic variants, and first described in 2014. TBRS is characterised by overgrowth, intellectual disability, facial dysmorphism, hypotonia and musculoskeletal...
6.
Boen H, Alaerts M, Van Laer L, Saenen J, Goovaerts I, Bastianen J, et al.
Front Genet . 2024 Jun; 15:1392527. PMID: 38836037
Background: Variants in the gene are a frequent cause of hypertrophic cardiomyopathy (HCM) but display a large phenotypic heterogeneity. Founder mutations are often believed to be more benign as they...
7.
Boen H, Cherubin M, Franssen C, Gevaert A, Witvrouwen I, Bosman M, et al.
JACC CardioOncol . 2024 May; 6(2):183-199. PMID: 38774014
Close monitoring for cardiotoxicity during anthracycline chemotherapy is crucial for early diagnosis and therapy guidance. Currently, monitoring relies on cardiac imaging and serial measurement of cardiac biomarkers like cardiac troponin...
8.
Valdivia Callejon I, Buccioli L, Bastianen J, Schippers J, Verstraeten A, Luyckx I, et al.
Int J Mol Sci . 2024 May; 25(9). PMID: 38732244
Cardiovascular outcome in Marfan syndrome (MFS) patients most prominently depends on aortic aneurysm progression with subsequent aortic dissection. Angiotensin II receptor blockers (ARBs) prevent aneurysm formation in MFS mouse models....
9.
Boen H, Alaerts M, Goovaerts I, Saenen J, Franssen C, Vorlat A, et al.
Cardiooncology . 2024 Apr; 10(1):26. PMID: 38689299
Background: Variants in cardiomyopathy genes have been identified in patients with cancer therapy-related cardiac dysfunction (CTRCD), suggesting a genetic predisposition for the development of CTRCD. The diagnostic yield of genetic...
10.
Adlam D, van Dijk F, Loeys B
Eur Heart J . 2024 Apr; 45(18):1610-1612. PMID: 38630854
No abstract available.